FDA — authorised 30 August 2002
- Application: NDA021428
- Marketing authorisation holder: TAKEDA PHARMS USA
- Local brand name: PREVACID
- Indication: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE — ORAL
- Status: approved
FDA authorised Prevacid on 30 August 2002
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 30 August 2002; FDA has authorised it.
TAKEDA PHARMS USA holds the US marketing authorisation.